Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells.
CD8-mediated inflammatory central nervous system disorders.
Methods and measures: what's new for MS?
Enhancement of Membrane B7-H3 Costimulatory Molecule but Reduction of Its Soluble Form in Multiple Sclerosis.
Molecular Dynamics of Multivalent Soluble Antigen Arrays Support Two-Signal Codelivery Mechanism in Treatment of Experimental Autoimmune Encephalomyelitis.
Phase IIa laquinimod trial results show positive data for potential use in active Crohn's disease
Therapeutic Armamentarium and Health System Coverage of Multiple Sclerosis in Latin America.
Proresolution lipid mediators in multiple sclerosis - differential, disease severity-dependent synthesis - a clinical pilot trial.
Accumulation of cortical hyperphosphorylated neurofilaments as a marker of neurodegeneration in multiple sclerosis.
Minocycline effects on the CSF proteome of Experimental Autoimmune Encephalomyelitis rats.
[Anti-NMDA receptor encephalitis - case report].
Concomitant amyotrophic lateral sclerosis and paraclinical laboratory features of multiple sclerosis: coincidence or causal relationship?
Impact of multiple sclerosis relapses on progression diminishes with time.
Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial.
Occupational Exposure and Risk of Central Nervous System Demyelination.
Central nervous system myeloid cells as drug targets: current status and translational challenges.
Association of Viruses in Neurodegenerative and Neurobehavioral Diseases.
The Ex Vivo Production of IL-6 and IL-21 by CD4(+) T Cells is Directly Associated with Neurological Disability in Neuromyelitis Optica Patients.
Charcot-Marie-Tooth Disease Type 4H Resulting from Compound Heterozygous Mutations in FGD4 from Nonconsanguineous Korean Families.
Hearing statement in multiple sclerosis: a case control study using auditory brainstem responses and otoacoustic emissions.
The effect of intravenous immunoglobulin on neuromyelitis optica.
Kv1.3 Deletion Biases T Cells toward an Immunoregulatory Phenotype and Renders Mice Resistant to Autoimmune Encephalomyelitis.
Brain MRI of nasal MOG therapeutic effect in relapsing-progressive EAE.
Case Studies: LAAM, Naltrexone, Clozapine, and Nicorette
Neuroprotection With Phenytoin in Optic Neuritis
Pages
« first
‹ previous
…
193
194
195
196
197
198
199
200
201
…
next ›
last »